Decoy Therapeutics（DCOY.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他98.73%
机构投资者0.80%
个人与内部人士0.48%

主要股东

主要股东最新
股东
Vanguard Capital Management, LLC	0.62%	4,034.00	--	+4,034.00	2026/06/30
Mark RosenblumExecutive VP of Finance & CFO	0.26%	1,681.00	0.06%	+0	2026/04/30
Frederick PierceCEO & Director	0.21%	1,389.00	0.05%	+0	2026/04/30
Geode Capital Management, LLC	0.14%	910.00	0.03%	+0	2025/12/31
Tower Research Capital Europe Limited	0.04%	256.00	0.15%	-765.00	2026/06/30
David ArthurFormer Director	<0.01%	34.00	<0.01%	+0	2026/04/30
UBS Asset Management AG	<0.01%	25.00	0.10%	-521.00	2026/06/30
Caitong International Asset Management Co., Limited	<0.01%	2.00	--	+2.00	2026/06/30
William McVicarIndependent Chairman of the Board	<0.01%	2.00	<0.01%	+0	2026/04/30
Arnold HanishIndependent Director	<0.01%	2.00	0.08%	-415.00	2026/04/30
Jonathan LieberIndependent Director	<0.01%	2.00	<0.01%	+0	2026/04/30
Teresa BurlesonIndependent Director	<0.01%	2.00	<0.01%	+0	2026/04/30
Bruce McCreedyFormer Interim Chief Scientific Officer & Independent Director	<0.01%	1.00	<0.01%	+0	2025/10/24
Paul LammersIndependent Director	<0.01%	1.00	<0.01%	+0	2026/04/30
Peter MarschelChief Business Officer	0.00%	0.00	--	+0	2026/04/30
Armistice Capital LLC	0.00%	0.00	0.08%	-421.00	2026/06/09
Morgan Stanley	0.00%	0.00	<0.01%	-1.00	2026/06/30
Barbara HibnerChief Scientific Officer	0.00%	0.00	--	+0	2026/04/30
Advisory Services Network, LLC	0.00%	0.00	<0.01%	-41.00	2026/06/30